MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.98
(1.36%)
EUR 2.98
(1.36%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 66.41 Million EUR | -85.32% |
| 2022 | 452.49 Million EUR | 26.33% |
| 2021 | 358.18 Million EUR | -11.79% |
| 2020 | 406.07 Million EUR | -8.02% |
| 2019 | 441.46 Million EUR | 703.76% |
| 2018 | 54.92 Million EUR | 45.17% |
| 2017 | 37.83 Million EUR | -16.93% |
| 2016 | 45.54 Million EUR | -3.9% |
| 2015 | 47.39 Million EUR | -12.41% |
| 2014 | 54.1 Million EUR | -10.61% |
| 2013 | 60.52 Million EUR | -9.61% |
| 2012 | 66.96 Million EUR | 195.1% |
| 2011 | 22.69 Million EUR | 9.31% |
| 2010 | 20.75 Million EUR | 28.75% |
| 2009 | 16.12 Million EUR | -23.66% |
| 2008 | 21.11 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 65.76 Million EUR | -0.5% |
| 2024 Q1 | 66.09 Million EUR | -0.49% |
| 2023 Q2 | 440.97 Million EUR | -1.27% |
| 2023 Q1 | 446.66 Million EUR | -1.29% |
| 2023 Q3 | 435.6 Million EUR | -1.22% |
| 2023 Q4 | 66.41 Million EUR | -84.75% |
| 2023 FY | 66.41 Million EUR | -85.32% |
| 2022 Q2 | 340.43 Million EUR | -3.21% |
| 2022 Q4 | 452.49 Million EUR | 37.98% |
| 2022 FY | 452.49 Million EUR | 26.33% |
| 2022 Q3 | 327.94 Million EUR | -3.67% |
| 2022 Q1 | 351.7 Million EUR | -1.81% |
| 2021 Q1 | 393.57 Million EUR | -3.08% |
| 2021 Q4 | 358.18 Million EUR | -3.33% |
| 2021 Q2 | 382.13 Million EUR | -2.91% |
| 2021 Q3 | 370.51 Million EUR | -3.04% |
| 2021 FY | 358.18 Million EUR | -11.79% |
| 2020 Q3 | 417.29 Million EUR | -2.65% |
| 2020 Q2 | 428.67 Million EUR | -1.62% |
| 2020 FY | 406.07 Million EUR | -8.02% |
| 2020 Q1 | 435.73 Million EUR | -1.3% |
| 2020 Q4 | 406.07 Million EUR | -2.69% |
| 2019 Q3 | 432.53 Million EUR | -2.27% |
| 2019 Q2 | 442.58 Million EUR | -2.32% |
| 2019 Q1 | 453.08 Million EUR | 724.9% |
| 2019 FY | 441.46 Million EUR | 703.76% |
| 2019 Q4 | 441.46 Million EUR | 2.07% |
| 2018 Q1 | 56.43 Million EUR | 49.17% |
| 2018 FY | 54.92 Million EUR | 45.17% |
| 2018 Q4 | 54.92 Million EUR | -1.11% |
| 2018 Q3 | 55.54 Million EUR | -0.81% |
| 2018 Q2 | 55.99 Million EUR | -0.79% |
| 2017 Q2 | 44.34 Million EUR | -0.78% |
| 2017 Q3 | 43.99 Million EUR | -0.79% |
| 2017 Q4 | 37.83 Million EUR | -13.99% |
| 2017 Q1 | 44.68 Million EUR | -1.88% |
| 2017 FY | 37.83 Million EUR | -16.93% |
| 2016 Q2 | 43.44 Million EUR | -0.91% |
| 2016 FY | 45.54 Million EUR | -3.9% |
| 2016 Q3 | 45.17 Million EUR | 4.0% |
| 2016 Q1 | 43.84 Million EUR | -7.49% |
| 2016 Q4 | 45.54 Million EUR | 0.81% |
| 2015 Q4 | 47.39 Million EUR | 17.61% |
| 2015 Q3 | 40.29 Million EUR | -6.56% |
| 2015 Q1 | 43.44 Million EUR | -19.7% |
| 2015 Q2 | 43.12 Million EUR | -0.75% |
| 2015 FY | 47.39 Million EUR | -12.41% |
| 2014 Q2 | 49.39 Million EUR | -0.62% |
| 2014 Q3 | 46.58 Million EUR | -5.69% |
| 2014 Q1 | 49.7 Million EUR | -17.88% |
| 2014 Q4 | 54.1 Million EUR | 16.15% |
| 2014 FY | 54.1 Million EUR | -10.61% |
| 2013 Q4 | 60.52 Million EUR | 14.86% |
| 2013 Q2 | 55.49 Million EUR | -4.8% |
| 2013 Q1 | 58.28 Million EUR | -12.95% |
| 2013 FY | 60.52 Million EUR | -9.61% |
| 2013 Q3 | 52.69 Million EUR | -5.04% |
| 2012 FY | 66.96 Million EUR | 195.1% |
| 2012 Q3 | 60.81 Million EUR | -12.72% |
| 2012 Q1 | 67.92 Million EUR | 199.34% |
| 2012 Q4 | 66.96 Million EUR | 10.11% |
| 2012 Q2 | 69.68 Million EUR | 2.59% |
| 2011 Q1 | 19.51 Million EUR | -5.97% |
| 2011 Q2 | 18.2 Million EUR | -6.72% |
| 2011 Q3 | 24.11 Million EUR | 32.43% |
| 2011 Q4 | 22.69 Million EUR | -5.89% |
| 2011 FY | 22.69 Million EUR | 9.31% |
| 2010 Q3 | 22.06 Million EUR | -6.71% |
| 2010 Q4 | 20.75 Million EUR | -5.91% |
| 2010 Q2 | 23.64 Million EUR | -5.75% |
| 2010 Q1 | 25.09 Million EUR | 55.62% |
| 2010 FY | 20.75 Million EUR | 28.75% |
| 2009 Q4 | 16.12 Million EUR | 0.0% |
| 2009 FY | 16.12 Million EUR | -23.66% |
| 2008 FY | 21.11 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.48 Billion EUR | 99.367% |
| Fresenius SE & Co. KGaA | 13.24 Billion EUR | 99.499% |
| LIMES Schlosskliniken AG | 10.09 Million EUR | -558.261% |
| M1 Kliniken AG | 1.87 Million EUR | -3442.337% |
| Maternus-Kliniken Aktiengesellschaft | 53.96 Million EUR | -23.082% |
| RHÖN-KLINIKUM Aktiengesellschaft | 141.77 Million EUR | 53.152% |
| VITA 34 AG | 3.38 Million EUR | -1860.993% |